Literatur
Gellermann J, Weber L, Pape L et al (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol Jasn 24:1689–1697. https://doi.org/10.1681/ASN.2012121200
Hackl Á, Cseprekál O, Gessner M et al (2016) Mycophenolate mofetil therapy in children with idiopathic Nephrotic syndrome: does therapeutic drug monitoring make a difference? Ther Drug Monit 38:274–279. https://doi.org/10.1097/FTD.0000000000000258
Schijvens AM, Ehren R, Weber LT, Schreuder MF (2019) The quest for optimal control of relapses in children with nephrotic syndrome. Kidney Int 95:717. https://doi.org/10.1016/j.kint.2019.01.002
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
R. Ehren gibt an, dass kein Interessenkonflikt besteht.
Additional information
Redaktion
T. Feldkamp, Kiel
J. Lutz, Mainz
L.T. Weber, Köln
Rights and permissions
About this article
Cite this article
Ehren, R. Mycophenolat-Mofetil und Levamisol zur Behandlung häufiger Rezidive eines idiopathischen nephrotischen Syndroms – neue Aspekte?. Nephrologe 14, 293–294 (2019). https://doi.org/10.1007/s11560-019-0333-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11560-019-0333-z